Charles B. Haaser - Feb 10, 2022 Form 4 Insider Report for YIELD10 BIOSCIENCE, INC. (YTEN)

Role
VP Fin and CAO
Signature
/s/ Megan N. Gates, attorney-in-fact
Stock symbol
YTEN
Transactions as of
Feb 10, 2022
Transactions value $
$21,459
Form type
4
Date filed
2/14/2022, 01:33 PM
Previous filing
Dec 7, 2021
Next filing
Mar 3, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction YTEN Common Stock Award $21.5K +5.6K +81.93% $3.83* 12.4K Feb 10, 2022 Direct F1
holding YTEN Common Stock 5K Feb 10, 2022 By 401(k) Plan F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction YTEN Stock Option (right to buy) Award $0 +18K $0.00 18K Feb 10, 2022 Common Stock 18K $3.83 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The securities awarded are in the form of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest as to 50% of the shares on 8/10/2022 and the remaining 50% on 2/10/2023.
F2 Shares acquired as Issuer matching contributions under the Yield10 Bioscience, Inc. 401(k) Plan.
F3 These options will vest and become exercisable in equal quarterly installments over 4 years from 2/10/2022, beginning on 5/10/2022 and ending on 2/10/2026.